FDA grants emergency clearance for GenMark test that screens for the flu, coronavirus and other viruses

Flu and Covid-19 patients typically develop similar symptoms early on in the virus, which could make it difficult this flu season for doctors and nurses to diagnose patients and pursue the best treatment. Tests like GenMark's that are able to simultaneously screen for the flu, the coronavirus and other pathogens could be crucial to helping hospitals effectively treat Covid-19 and influenza patients this winter, public health specialists say.

"While we can't predict what cold and flu season is going to look like this year, we know that we have to arm healthcare providers with the necessary tools to quickly and accurately diagnose the cause of infections in seriously ill patients, so syndromic testing is going to be critical," Scott Mendel, GenMark's CEO, said in a statement.

The test, called ePlex Respiratory Pathogen Panel 2, provides results in less than two hours, according to the company. It added that the test was funded in part by the Biomedical Advanced Research and Development Authority, which is a part of the Department of Health and Human Services.a GenMark's diagnostic test for the coronavirus.

Geez now game

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Side-Steps White House, Releases More Stringent Guidelines For Approving A Covid-19 VaccineThe public release of the documents marks another instance of health departments and the White House butting heads during the pandemic, with the Centers for Disease Control and Prevention being the center to much of the chaos. Good. About time someone puts trump in his place andyroddick No one is talking about how this additional 2 months observation period for emergency use can cause thousands of deaths which could be avoided by vaccinating the vulnerable. All to stick it to a president. Americans can be nuts
Source: Forbes - 🏆 394. / 53 Read more »